English
Home > Products > Metaraminol advance intermediate

China Metaraminol advance intermediate Factory

We believe in: Innovation is our soul and spirit. Quality is our life. Customer need is our God for Metaraminol advance intermediate,CAS NO 82499-20-5,82499-20-5,Metaraminol intermediate,(R)-1-hydroxy-1-(3-hydroxyphenyl)propan-2-one, With our rules of " organization track record, partner trust and mutual benefit", welcome all of you to function together , improve jointly.
Metaraminol advance intermediate, We always adhere to follow the honesty, mutual benefit, common development, after years of development and the tireless efforts of all staff, now has perfect export system, diversified logistics solutions, extensive meet customer shipping, air transport, international express and logistics services. Elaborate one-stop sourcing platform for our customers!

Related Products

Hot Products

  • L-Tryptophan

    L-Tryptophan

    Product Name:L-Tryptophan
    Molecular Formula:C11H12N2O2
    Molecular Weight;204.23
    CAS Registry Number;73-22-3/80206-30-0
  • (αR)-α-(2-Chlorophenyl)-2H-tetrazole-2-ethanol

    (αR)-α-(2-Chlorophenyl)-2H-tetrazole-2-ethanol

    Product Name:(αR)-α-(2-Chlorophenyl)-2H-tetrazole-2-ethanol
    Molecular Formula:C9H9ClN4O
    Molecular Weight:224.65
    CAS Registry Number:1259059-77-2
  • Calcobutrol

    Calcobutrol

    Product Name:Calcobutrol
    Molecular Formula:C18H36CaN4O9
    Molecular Weight:492.58
    CAS Registry Number:151878-23-8
  • Gentamicin Injection

    Gentamicin Injection

    Product Name:Gentamicin Injection
    Dosage:80mg/2ml
    Dosage:1ml: 40mg
    Dosage:2ml: 80mg
    Application:Antibiotics
  • (R)-2-(2,5-difluorophenyl)pyrrolidine (R)-2-hydroxysuccinate

    (R)-2-(2,5-difluorophenyl)pyrrolidine (R)-2-hydroxysuccinate

    Product Name:(R)-2-(2,5-difluorophenyl)pyrrolidine (R)-2-hydroxysuccinate
    Molecular Formula:C14H17F2NO5
    Molecular Weight:317.29
    CAS Registry Number:1919868-77-1
  • Dabrafenib

    Dabrafenib

    Product Name:Dabrafenib
    Molecular Formula:C23H20F3N5O2S2
    Molecular Weight;519.56
    CAS Registry Number;1195765-45-7
  • Related Blog
  • Reviews

  • How is a drug produced?

    ​There are so many different drugs ,with different color /shape ( like capsule ,tablet or Infusion) and price . Here we would like to explain , what makes it so different? How is a drug produced?

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • What are pharmaceutical intermediates?

    Pharmaceutical intermediates are fine chemical products in the production process from pharmaceutical chemical raw materials to bulk drugs or drugs. The synthesis of chemical drugs depends on high-quality pharmaceutical intermediates. This chemical, which does not require a drug production license, can be produced in ordinary chemical plants and can be used in the synthesis of drugs as long as it reaches certain grades.

  • CAS No. 144689-24-7 Olmesartan Introduction

    Olmesartan is an angiotensin II receptor blocker, widely used for the treatment of hypertension. The Renin-Angiotensin-Aldosterone System (RAAS) plays an importent role in the development and progression of many diseases such as hypertension...

  • What is Coenzyme Q10 CAS NO.303-98-0

    Coenzyme Q10 (CAS NO.303-98-0 ) is a fat-soluble antioxidant, which can activate the nutrition of human cells and cellular energy, and has the functions of improving human immunity, enhancing antioxidation, delaying ageing and enhancing human vitality.

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept